Table 2 Laboratory and imaging information of the patients that received IVT treatment

Serum glucose level (mmol/L), median [IQR]

6.89 [5.89–8.75]

6.84 [5.89–8.62]

7.19 [5.97–9.29]

6.84 [5.57–8.01]

6.55 [5.92–8.09]

7.50 [6.01–9.30]

.616

HbA1c (%), median [IQR]

6.00 [5.70–6.82]

6.00 [5.70–6.60]

6.00 [5.65–7.10]

6.25 [5.62–7.20]

5.95 [5.80–6.30]

6.20 [5.75–6.90]

.75

LDL level (mmol/L), mean (SD)

2.56 ± 0.84

2.68 ± 0.81

2.79 ± 0.95

2.44 ± 0.85

2.27 ± 0.87

2.19 ± 0.62

.001

Cholesterol level (mmol/L), mean (SD)

4.18 ± 0.97

4.30 ± 0.92

4.49 ± 1.07

4.09 ± 1.04

3.76 ± 0.93

3.75 ± 0.81

.001

ASPECTS score, median [IQR]

8 [7–9]

9 [8-9]

10 [10-10]

9 [8–10]

8 [7–9]

8 [6–9]

.279

MR DWI positive, n(%)

297 (86.6)

166 (83.8)

38 (86.4)

24 (92.3)

25 (89.3)

44 (93.6)

.323

Fazekas scale, median [IQR]

1 [1-2]

1 [1-1]

1 [1-2]

1 [1-2]

2 [1-2]

1 [1-2]

.001

Cranial vessel stenosis location, n(%)

.110

ACA

5 (3.2)

3 (3.5)

0 (0.0)

0 (0.0)

0 (0.0)

2 (7.7)

MCA

77 (50.0)

43 (50.0)

10 (58.8)

4 (12.5)

7 (53.8)

13 (50.0)

PCA

15 (9.7)

10 (11.6)

3 (17.6)

2 (16.7)

0 (0.0)

0 (0.0)

ICA

38 (24.7)

22 (25.6)

2 (11.8)

5 (41.7)

4 (30.8)

5 (19.2)

VA

3 (1.9)

1 (1.2)

0 (0.0)

1 (8.3)

1 (7.7)

0 (0.0)

BA

16 (10.4)

7 (8.1)

2 (11.8)

0 (0.0)

1 (7.7)

6 (23.1)

Stenosis degree, n(%)

.548

 ≤ 70%

302 (68.8)

176 (68.2)

38 (69.1)

20 (62.5)

23 (65.7)

45 (75.0)

70–99%

50 (11.4)

33 (12.8)

7 (12.7)

5 (15.6)

2 (5.7)

3 (5.0)

Occlusion

88 (20.0)

49 (19.0)

10 (18.2)

7 (21.9)

10 (28.6)

12 (20.0)

sICH-ECASS II, n(%)

17 (3.9)

4 (1.6)

5 (9.1)

0 (0.0)

1 (2.9)

7 (11.7)

.002

sICH-SITS, n(%)

10 (2.3)

2 (0.8)

4 (7.3)

0 (0.0)

0 (0.0)

4 (6.7)

.001